Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linn Woelber

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Anticancer Research|July 15, 2009
Prognostic significance of CA-125 in the management of patients with recurrent epithelial ovarian carcinoma selected for secondary cytoreductionSven Mahner, Linn Woelber, Sabine Jung, et al.
Gynecologic Oncology|January 7, 2010
Serum carbonic anhydrase IX during first-line therapy of ovarian cancerLinn Woelber, Volkmar Mueller, Christine Eulenburg, et al.
Anticancer Research|April 1, 2009
Clinicopathological prognostic factors and patterns of recurrence in vulvar cancerLinn Woelber, Sven Mahner, Katharina Voelker, et al.
BMC Cancer|April 15, 2010
TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patientsSven Mahner, Linn Woelber, Christine Eulenburg, et al.
Geburtshilfe Und Frauenheilkunde|April 23, 2026
INTERLACE Study: Real-world Data for Germany Based on a Case Series of Patients with Locally Advanced Cervical CancerAlina Lohner, Volkmar Müller, Andrea Baehr, et al.
Journal of Cancer Research and Clinical Oncology|February 24, 2011
Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancerDina Mury, Linn Woelber, Sabine Jung, et al.
Annals of Surgical Oncology|November 8, 2012
Secondary sentinel node biopsy after previous excision of the primary tumor in squamous cell carcinoma of the vulvaLinn Woelber, Donata Grimm, Eik Vettorazzi, et al.
Expert Review of Anticancer Therapy|July 24, 2013
Adjuvant therapy in node-positive vulvar cancerSven Mahner, Fabian Trillsch, Lilli Kock, et al.
Frontiers in Oncology|October 27, 2015
Beyond Bevacizumab: An Outlook to New Anti-Angiogenics for the Treatment of Ovarian CancerSven Mahner, Linn Woelber, Volkmar Mueller, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2011
Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancerLilli Kock, Sven Mahner, Matthias Choschzick, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Anticancer Research|July 15, 2009
Prognostic significance of CA-125 in the management of patients with recurrent epithelial ovarian carcinoma selected for secondary cytoreductionSven Mahner, Linn Woelber, Sabine Jung, et al.
Gynecologic Oncology|January 7, 2010
Serum carbonic anhydrase IX during first-line therapy of ovarian cancerLinn Woelber, Volkmar Mueller, Christine Eulenburg, et al.
Anticancer Research|April 1, 2009
Clinicopathological prognostic factors and patterns of recurrence in vulvar cancerLinn Woelber, Sven Mahner, Katharina Voelker, et al.
BMC Cancer|April 15, 2010
TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patientsSven Mahner, Linn Woelber, Christine Eulenburg, et al.
Geburtshilfe Und Frauenheilkunde|April 23, 2026
INTERLACE Study: Real-world Data for Germany Based on a Case Series of Patients with Locally Advanced Cervical CancerAlina Lohner, Volkmar Müller, Andrea Baehr, et al.
Journal of Cancer Research and Clinical Oncology|February 24, 2011
Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancerDina Mury, Linn Woelber, Sabine Jung, et al.
Annals of Surgical Oncology|November 8, 2012
Secondary sentinel node biopsy after previous excision of the primary tumor in squamous cell carcinoma of the vulvaLinn Woelber, Donata Grimm, Eik Vettorazzi, et al.
Expert Review of Anticancer Therapy|July 24, 2013
Adjuvant therapy in node-positive vulvar cancerSven Mahner, Fabian Trillsch, Lilli Kock, et al.
Frontiers in Oncology|October 27, 2015
Beyond Bevacizumab: An Outlook to New Anti-Angiogenics for the Treatment of Ovarian CancerSven Mahner, Linn Woelber, Volkmar Mueller, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 19, 2011
Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancerLilli Kock, Sven Mahner, Matthias Choschzick, et al.
Pageof 11